Clinical evaluation of germline polymorphisms (SNPs) associated with disease response to capecitabine in metastatic breast cancer (MBC) (TBCRC 015).
Year: 2018
Type: conference-abstract
Source: Journal of Clinical Oncology
Authors: Noura Choudhury, Patrick Evans, James N. Ingle, Ingrid A. Mayer, Phuong Khanh H. Morrow, Anna Maria Storniolo, Andres Forero-Torres, Catherine H. Van Poznak, Douglas E. Merkel, Elizabeth Claire Dees, Gini F. Fleming, Olwen Mary Hahn, Philip C. Hoffman, Olufunmilayo I. Olopade, Nancy Cox, Rita Nanda, Peter H. O'Donnell
Institutions: University of Chicago, Vanderbilt University, Mayo Clinic, Vanderbilt-Ingram Cancer Center, Amgen (United States), Indiana University Health, Indiana University Indianapolis, Indiana University Melvin and Bren Simon Comprehensive Cancer Center, University of Alabama at Birmingham, U-M Rogel Cancer Center, Endeavor Health, Evanston Hospital, University of North Carolina at Chapel Hill, University of Chicago Medical Center, University of Chicago Medicine Comprehensive Cancer Center
Language: English
Subfield: Pharmacology
Domain: Life Sciences
Open Access status: closed
OpenAlex ID: W2805689119
